TQS-168 receives orphan drug status, aiding als treatment development
ALS News Today - 24-Jun-2022Early trials show safety, tolerability, and promising results in preclinical studies
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Science journalist
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
Visit website: https://alsnewstoday.com/author/lindsey-shapiro/
See alsoDetails last updated 11-Dec-2024
Early trials show safety, tolerability, and promising results in preclinical studies